Plain-English translation of NCT06579157 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new technology called a pressure-sensing mattress (also called ballistocardiography) that can measure a baby's heart and breathing patterns without any devices attached to their body. Researchers want to see if this mattress can accurately track the same information as the machines currently used in neonatal intensive care units, and whether it might help predict complications like chronic lung disease in premature babies.
Current monitoring methods often require uncomfortable devices attached directly to newborns' bodies, which can cause distress and limit their movement. This trial exists to explore whether this new technology could provide the same vital health information in a gentler, non-invasive way, especially for fragile premature infants.
You likely qualify if…
You likely don't qualify if…
Your baby would lie on a special pressure-sensing mattress during their hospital stay in the neonatal intensive care unit. While your baby receives their regular breathing support and care, the mattress silently collects heart and breathing information every day. Researchers will compare this mattress data with information from the standard monitoring machines your baby is already using. There are no extra procedures or visits — the mattress simply works alongside your baby's regular care.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
Taiwan
Sponsor
Fu Jen Catholic University
Enrollment target
~60 participants
Started
November 2024
Primary completion
July 2027
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ke-Yun Chao, PhD
Fu Jen Catholic University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.